Physician profile
Auday Lopez
NPI 1508079153
$851.60
in general payments reported to CMS, 2019-2025
9 companies · $188 in 2025
The $188 reported for 2025 was more than what 78% of Occupational Medicine providers received nationally (typical 2025 total: $53.66).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.94 · 2022: $330 · 2023: $93.65 · 2024: $207 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $288.78 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $132.24 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $123.08 | 2022 | |
| Genmab U.S., INC. | $106.92 | 2024-2025 | Epkinly |
| Janssen Pharmaceuticals, INC | $67.77 | 2021-2025 | Tecvayli, Darzalex |
| Eli Lilly Export S.A. Puerto Rico Branch | $45.00 | 2024 | Jaypirca, Retevmo, Verzenio |
| Regeneron Healthcare Solutions, INC. | $38.84 | 2025 | Lynozyfic |
| Kyowa Kirin, INC. | $25.00 | 2023 | Poteligeo |
| Sanofi-Aventis U.S. LLC | $23.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Auday Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.